Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Clinical trial NCT03445663 · TERMINATED
Trial details
- NCT number
- NCT03445663
- Sponsor
- Xencor, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2020-06-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.